Carl Lukach
Analyst · Merrill Lynch
Okay, thanks Jeff. Everyone will move to our platform review. Let’s begin with our Ag & Nutrition platform on slide 11. Sales grew 23% to $1.3 billion. Underlying earnings improved 40% from a loss of $148 million in the fourth quarter last year to a loss of $89 million this quarter. I'd like to point out that the fourth quarter this year includes a gain of $15 million related to a crop, chemical assets divestiture. Excluding this gain, our PTOI for the platform grew 30% quarter-over-quarter. The strong performance delivered by our Ag platform was driven by strong international sales across the platform and across all regions coupled with cost productivity improvements from the restructuring program we announced to you one year ago. I will give you the details beginning with crop protection product. Sales and earnings were up significantly driven by strong regional demand and buoyed by favorable pricing in Latin America. Insecticide demand was particularly strong in Latin America and Europe. Asia-Pacific volume was up significantly driven by demand for [inaudible] in Japan and broad market growth across the region. Margins expanded on favorable pricing and fixed cost productivity gains. Moving to seeds, fourth quarter sales at Pioneer increased 40%, led by substantial growth in Latin America and Asia and early season sales in Europe and North America. Last quarter we described the strong season under way in Latin America. That strong momentum carried through the fourth quarter as well. Corn market share was up four to five points in Brazil and Argentina on expanding acreage in both countries. In fact, 2007 was the fifth consecutive year of share gains for corn and soybeans in Brazil. For the full-year 2007, our seed business PTOI represented about two thirds of total platform PTOI and in 2007 earned an 18% pretax margin. This includes our incremental growth spending in 2007 of about $100 million. We are already seeing a return on our investments in our seeds sales team and in R&D. Overall we're pleased with the 23% platform growth in PTOI in 2007. Let's turn now to the outlook for the Ag and Nutrition platform for the first quarter. Our order books for the North American growing season are strong. Platforms sales and earnings will be up low double digits driven by strong seed sales in North America and chemical sales in Europe and Latin America, moderated by higher commodity costs and continued growth in investment spending. Okay, let's move now to slide 12, Coatings & Color Technologies segment. Sales increased 8% to $1.7 billion, earnings grew to $216 million, up 5%. Earnings grew substantially in our coatings business, reflecting the results of our restructuring efforts and increased sales, but were partially offset by modest declines in TiO2 earnings and the absence of gains from asset sales in last year's fourth quarter. TiO2 product sales increased slightly. US dollar price was up in Europe and Asia, volumes were up in Asia and Brazil, but volumes were lower in North America and Mexico reflecting lower demand from our paint customers selling into the North American residential housing market. Earnings for TiO2 declined modestly. The coatings businesses increased sales moderately, but earnings improved substantially as our teams continue to execute on two key strategies. Number one, restructuring the cost base and number two, reorienting our business towards faster growth markets. As proof point, fixed cost as a percentage of sales improved 195 basis points and sales outside the US grew 10% and as Jeff mentioned, the collision paint plants in Shanghai, China started up on time and on budget. For a little longer term perspective on the status of our coatings transformation, after two years of transformed work and despite the North American market conditions, our coatings business grew the topline on average 17% in Latin America and Asia and grew global earnings on average 22%. The key growth drivers in this platform are continued growth in emerging markets, penetration to new markets, pricing actions and productivity gains. As Jeff noted, we are not expecting improved conditions in North America housing or auto markets in 2008. Specifically our first quarter outlook for Coatings and Color Technologies reflect modest earnings growth, partially offset by the inclusion in the first quarter '07 of $60 million in insurance recovery. Moving now to slide 13 and our Electronics & Communication Technologies platform. Sales grew 13% to $1 billion; earnings increased substantially to $156 million and included a $28 million gain on our land sale. Excluding this gain, earnings grew 14%. Our fourth quarter performance reflects continuous improvement from the first half for several key product lines. Fourth-quarter sales growth was driven by volume growth in fluroproducts and electronic materials. Strong demand for photovoltaic materials continued while sales for electronic materials rebounded in the quarter, particularly for the semiconductor and plasma displays supply chains. Platforms earnings improvement reflected sales gains and cost control, partially offset by changing business mix. Earnings growth was particularly strong in our fluroproducts, electronic materials and packaging product lines. Turning to the outlook for the first quarter, we expect to generate modest sales growth. We anticipate benefiting from strong demand for photovoltaic, improved demand for electronic materials and continued cost control. Earnings however should grow significantly in the first quarter driven by an improved product mix versus the first quarter ‘06. I'll turn to slide 14 now and review our Performance Materials segment. Sales grew 12% to $1.7 billion, particularly on the high US dollar selling prices. Excluding significant items in both periods, earnings increased 54% to $186 million reflecting gains in all product lines. The segment’s profit improvement reflects higher US dollar selling prices and disciplined fixed cost management, which were partially offset by higher raw material cost and a charge to write down certain manufacturing assets. We experienced global sales gains in all three major product lines. From a regional perspective, revenues grew in Latin America, Asia, and Europe due to US dollar selling price gains and volume growth. In North America however, volume declined, but sales were up slightly. Looking forward to 2008, the segment will face difficult comparison to its strong '07 results. However, we expect continued growth reflecting growth in emerging markets, higher US dollar selling prices, fixed cost discipline and successful launches in new products applications. These gains are anticipated to be partially offset by higher raw material cost, continued softness in the North American auto and housing markets and costs related to shut down of a European production facility at our company's Louisville, Kentucky plant. Specifically for the first quarter, we expect modest sales gain and slight earnings growth compared with the strong comparable results in prior year's first quarter. US dollar pricing and cost management will be partially offset by higher raw material costs and plant shutdown costs. Turning to slide 15 and looking at our sales and our Safety and Protection segment, sales increased to $1.4 billion, up 5% excluding the impact of divested business. Earnings in the quarter were $277 million, up 13% versus previous year. The quarter and the year closed strong with diversity of the S&P products, markets and geographies continues to support growth in the phase of continuing slowing in the US residential housing market. Sales growth in all regions continued double-digit growth in emerging markets. Kevlar and Nomex demand remains strong across most market segments. Global sales by our building innovation business was about flat, even though US housing starts were down about 25%, as sales growth outside the US mostly offset lower US sales. The combination of topline growth, fixed cost productivity particularly in chemicals and favorable currency were the key elements for achieving a double-digit PTOI growth. For full year 2008, we see solid fundamentals for safety and security products globally. The key growth drivers are continued non-US penetration, new product introductions, Nomex capacity expansion and enriching the product offering. The growth would be tampered by continue weakness in US housing and cost increases of fund growth such as Kevlar capacity investments. Specifically for the first quarter, safety and protection expect modest earnings growth reflecting expansion related activities in the Nomex business. Lastly our Applied BioSciences technology platform, we have two milestones to report on since our investor meeting just 8 weeks ago. First, in our Biomedical business, we signed a strategic collaboration with BioSphere Medical under which the companies will evaluate potential peripheral vascular and embolotherapy research and new product development. We will also apply DuPont's know-how to the manufacturing of BioSphere, Embosphere and EmboGold product in an effort to accelerate the improvement of manufacturing yield by these products. Second in our BioSurfaces business, we signed a new co-development agreement with a major downstream partner to commercialize new products based on DuPont's innovative BioSurfaces technology. That concludes the review of our platforms. I'll now turn the call back to Chad.